“…Posttransplantation lymphoproliferative disorder (PTLD) can be observed in all age groups after transplantation of the kidney, liver, heart, lung, or bone marrow [17]. Taking all solid organ transplants together, the incidence of PTLD is approximately 2-3% [2,3,7,14,17,23]. However, kidney recipients are at a lower risk than heart or lung recipients due to the different immunosuppression regimens [14,17,24].…”